Ortivity Secures Strategic Partnership with Unigestion for Expansion
Deal News | Aug 25, 2025 | Apheon (prev Ergon Capital)
Apheon, a prominent pan-European private equity investor, has announced the completion of a significant investment in Ortivity, Germany's leading outpatient orthopaedic care platform. The transaction involves a new partnership with Unigestion, a private equity firm focusing on mid-market investments, alongside select new investors, aiming to enhance Ortivity’s strategic growth in Germany's orthopaedic care sector. The deal includes a capital injection of approximately EUR 200 million, facilitating a partial exit for current Ortivity shareholders while maintaining Apheon as the lead investor. Founded in 2022, Ortivity has rapidly developed a strong presence in Germany, operating over 100 sites with a full spectrum of orthopaedic services. The partnership with Unigestion will allow Ortivity to further its mission of modernising orthopaedic care, expanding within existing regions, and establishing new clusters across the country. The transaction is subject to regulatory approval, with Apheon having selected Houlihan Lokey as its exclusive financial advisor and Renzenbrink & Partner as legal advisors.
Sectors
- Private Equity
- Healthcare
- Investment Banking
- Legal Services
Geography
- Germany – Ortivity operates over 100 medical centers in Germany, making it a key geographical focus.
- Pan-European – Apheon is a pan-European private equity firm, indicating broader geographic interests and activities across Europe.
Industry
- Private Equity – The investment involves private equity firms Apheon and Unigestion in financing the expansion of Ortivity.
- Healthcare – Ortivity operates in the outpatient healthcare sector, providing orthopaedic services across Germany.
- Investment Banking – Houlihan Lokey acted as a financial advisor, indicating involvement in investment banking services for the transaction.
- Legal Services – Renzenbrink & Partner provided legal advisory services to Apheon in the transaction.
Financials
- EUR 200 million – The capital injection into Ortivity by Unigestion and other investors.
Participants
Name | Role | Type | Description |
---|---|---|---|
Ortivity | The Target Company | Company | Germany's leading outpatient orthopaedic care platform. |
Apheon | Private Equity Investor | Company | Pan-European midmarket private equity firm, lead investor in Ortivity. |
Unigestion | The Bidding Company | Company | Private equity firm investing in Ortivity, focusing on mid-market companies. |
Houlihan Lokey | Financial Advisor | Company | Provided financial advisory services to Apheon in the transaction. |
Renzenbrink & Partner | Legal Advisor | Company | Provided legal advisory services to Apheon in the transaction. |
Dr. med. Reinhard Wichels | Co-Founder | Person | Physician, co-founder of Ortivity. |
Nils Lssem | Partner at Apheon | Person | Involved in orchestrating the investment partnership with Unigestion. |
Sebastian Walter | Director at Apheon | Person | Participated in the investment decision-making with Unigestion. |
Philipp Scheier | Partner at Unigestion | Person | Involved in managing the investment relationship with Ortivity. |